|
Peptides
NIK Peptide
Background
NIK (C-Terminus) Peptide
Location
17 amino acids near the carboxy terminus of human NIK.
Application
NIK peptide is used for blocking the activity of Anti-NIK (Cat. No. 1129). Incubating the peptide with equal volume of antibody for 30 min at 37˚C usually completely blocks the antibody activity in Western blotting.
Tested Application
Bl
Buffer
PBS containing 0.02% sodium azide
Storage
NIK peptide is supplied as 200 μg/ml, 50 μg/vial, in PBS pH7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide. Store at -20˚C, stable for one year.
Species Reactivity
n/a
Species
H
Short Description
(CT) NIK peptide
This product belongs to the following categories:
Related Products
References- Kitaura M, Nakajima T, Imai T, et al. Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3. J Biol Chem 1996;271:7725-30
- Ponath PD, Qin S, Ringler DJ, et al. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest 1996;97:604-12
- He J, Chen Y, Farzan M, et al. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature. 1997;385(6617):645-9
- Choe H, Farzan M, Sun Y, et al. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell. 1996;85:1135-48 (WD0500)
Datasheet 0801-W
|
|
